RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
0.879
+0.019 (2.15%)
At close: Jun 26, 2026, 4:00 PM EDT
0.852
-0.026 (-3.00%)
Pre-market: Jun 29, 2026, 7:00 AM EDT
RedHill Biopharma Employees
RedHill Biopharma had 13 employees as of December 31, 2025. The number of employees decreased by 22 or -62.86% compared to the previous year.
Employees
13
Change (1Y)
-22
Growth (1Y)
-62.86%
Revenue / Employee
$22,000
Profits / Employee
-$33,000
Market Cap
5.34M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Biofrontera | 94 |
| Sunshine Biopharma | 50 |
| cbdMD | 42 |
| InMed Pharmaceuticals | 13 |
| Sonoma Pharmaceuticals | 10 |
| Gelteq | 8 |
| PRF Technologies | 7 |
| Caring Brands | 3 |
RDHL News
- 6 days ago - RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement - PRNewsWire
- 10 days ago - RedHill Biopharma announces $19.4M private placement - TheFly
- 10 days ago - RedHill Biopharma Announces Up To $19.4 Million Private Placement - PRNewsWire
- 12 days ago - RedHill (RDHL) Gains FDA Rare Pediatric Disease Designation, Opening Door to Potential Priority Review Voucher (PRV) Upside - TipRanks
- 18 days ago - RedHill Biopharma’s Opaganib Ebola Plan Gives RDHL Stock a New Catalyst - TipRanks
- 20 days ago - RedHill Biopharma’s opaganib granted FDA Rare Pediatric Disease designation - TheFly
- 20 days ago - RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation - PRNewsWire
- 21 days ago - RedHill Biopharma launches enforcement of $11M judgment against Kukbo - TheFly